Neuberger Berman Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Sell
11,818
-194
-2% -$52.5K ﹤0.01% 1064
2025
Q4
$3.01M Sell
12,012
-597
-5% -$159K ﹤0.01% 1076
2025
Q3
$3.62M Sell
12,609
-5,995
-32% -$1.61M ﹤0.01% 1032
2025
Q2
$4.88M Buy
18,604
+1,125
+6% +$274K ﹤0.01% 972
2025
Q1
$4.07M Buy
17,479
+1,081
+7% +$262K ﹤0.01% 973
2024
Q4
$3.76M Buy
16,398
+5,225
+47% +$1.2M ﹤0.01% 1001
2024
Q3
$2.5M Buy
11,173
+2,596
+30% +$571K ﹤0.01% 1082
2024
Q2
$1.75M Sell
8,577
-12,712
-60% -$2.59M ﹤0.01% 1130
2024
Q1
$4.65M Buy
21,289
+4,138
+24% +$912K ﹤0.01% 944
2023
Q4
$3.9M Buy
17,151
+9,333
+119% +$1.96M ﹤0.01% 969
2023
Q3
$1.57M Sell
7,818
-1,230
-14% -$259K ﹤0.01% 1138
2023
Q2
$1.88M Buy
9,048
+49
+0.5% +$9.51K ﹤0.01% 1098
2023
Q1
$1.77M Sell
8,999
-120
-1% -$24.7K ﹤0.01% 1112
2022
Q4
$1.84M Buy
9,119
+56
+0.6% +$10.9K ﹤0.01% 1085
2022
Q3
$1.59M Sell
9,063
-435
-5% -$89.1K ﹤0.01% 1137
2022
Q2
$1.91M Buy
9,498
+916
+11% +$195K ﹤0.01% 1123
2022
Q1
$1.94M Buy
8,582
+440
+5% +$103K ﹤0.01% 1178
2021
Q4
$2.03M Buy
8,142
+1,790
+28% +$443K ﹤0.01% 1189
2021
Q3
$1.41M Sell
6,352
-3,028
-32% -$763K ﹤0.01% 1238
2021
Q2
$2.12M Buy
9,380
+85
+0.9% +$19.4K ﹤0.01% 1165
2021
Q1
$1.95M Buy
9,295
+375
+4% +$75.3K ﹤0.01% 1160
2020
Q4
$1.54M Buy
8,920
+77
+0.9% +$13.3K ﹤0.01% 1154
2020
Q3
$1.43M Sell
8,843
-219
-2% -$34.7K ﹤0.01% 1127
2020
Q2
$1.29M Sell
9,062
-66
-0.7% -$9.13K ﹤0.01% 1088
2020
Q1
$991K Buy
9,128
+45
+0.5% +$6.48K ﹤0.01% 1097
2019
Q4
$1.32M Buy
9,083
+476
+6% +$68.7K ﹤0.01% 1102
2019
Q3
$1.24M Sell
8,607
-9
-0.1% -$1.31K ﹤0.01% 1108
2019
Q2
$1.28M Sell
8,616
-273
-3% -$38.1K ﹤0.01% 1111
2019
Q1
$1.17M Sell
8,889
-5,812
-40% -$716K ﹤0.01% 1079
2018
Q4
$1.6M Sell
14,701
-1,850
-11% -$248K ﹤0.01% 1021
2018
Q3
$2.47M Sell
16,551
-2,173
-12% -$331K ﹤0.01% 1006
2018
Q2
$2.91M Sell
18,724
-899
-5% -$136K ﹤0.01% 994
2018
Q1
$2.75M Buy
19,623
+4,241
+28% +$623K ﹤0.01% 974
2017
Q4
$2.14M Sell
15,382
-11,683
-43% -$1.54M ﹤0.01% 1013
2017
Q3
$3.51M Buy
27,065
+1,543
+6% +$206K ﹤0.01% 911
2017
Q2
$3.38M Buy
25,522
+8,043
+46% +$985K ﹤0.01% 922
2017
Q1
$2.15M Sell
17,479
-422
-2% -$50K ﹤0.01% 989
2016
Q4
$1.97M Sell
17,901
-2,299
-11% -$255K ﹤0.01% 1005
2016
Q3
$2.39M Buy
20,200
+10,156
+101% +$1.2M ﹤0.01% 944
2016
Q2
$1.12M Buy
10,044
+4,948
+97% +$532K ﹤0.01% 1070
2016
Q1
$513K Sell
5,096
-616
-11% -$59.1K ﹤0.01% 1254
2015
Q4
$607K Sell
5,712
-18
-0.3% -$1.86K ﹤0.01% 1226
2015
Q3
$534K Buy
5,730
+284
+5% +$29.4K ﹤0.01% 1276
2015
Q2
$567K Buy
5,446
+280
+5% +$29.1K ﹤0.01% 1306
2015
Q1
$560K Buy
5,166
+124
+2% +$12.8K ﹤0.01% 1321
2014
Q4
$467K Sell
5,042
-794,550
-99% -$70.2M ﹤0.01% 1364
2014
Q3
$69.9M Sell
799,592
-225,816
-22% -$20.4M 0.07% 352
2014
Q2
$90.2M Buy
1,025,408
+908,389
+776% +$78.7M 0.09% 324
2014
Q1
$9.87M Buy
117,019
+76,127
+186% +$6.07M 0.01% 801
2013
Q4
$3.21M Sell
40,892
-48,913
-54% -$4.17M ﹤0.01% 966
2013
Q3
$7.65M Sell
89,805
-265,684
-75% -$22.4M 0.01% 835
2013
Q2
$30.6M Buy
+355,489
New +$29.5M 0.04% 499

Other funds holding LH

Neuberger Berman Group's LH Position: Q1 2026 in Review

Neuberger Berman Group reduced its Labcorp (LH) stake by 1.6% in Q1 2026, selling an estimated $52.5K and leaving 11,818 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Neuberger Berman Group first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $90.2M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Neuberger Berman Group held 11,818 shares of Labcorp worth $3.15M as of Q1 2026.
  • Neuberger Berman Group sold 194 Labcorp shares in Q1 2026, an estimated $52.5K.
  • Labcorp made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1064 holding.
  • Neuberger Berman Group first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's Labcorp position peaked at $90.2M in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.